Karageorgos LE - Search Results

1

Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage.

Isaac EL, Karageorgos LE, Brooks DA, Hopwood JJ, Meikle PJ. Isaac EL, et al. Among authors: karageorgos le. Exp Cell Res. 2000 Feb 1;254(2):204-9. doi: 10.1006/excr.1999.4755. Exp Cell Res. 2000. PMID: 10640418

2

Structure and sequence of the human sulphamidase gene.

Karageorgos LE, Guo XH, Blanch L, Weber B, Anson DS, Scott HS, Hopwood JJ. Karageorgos LE, et al. DNA Res. 1996 Aug 31;3(4):269-71. doi: 10.1093/dnares/3.4.269. DNA Res. 1996. PMID: 8946167 Free article.

3

Lysosomal biogenesis in lysosomal storage disorders.

Karageorgos LE, Isaac EL, Brooks DA, Ravenscroft EM, Davey R, Hopwood JJ, Meikle PJ. Karageorgos LE, et al. Exp Cell Res. 1997 Jul 10;234(1):85-97. doi: 10.1006/excr.1997.3581. Exp Cell Res. 1997. PMID: 9223373

4

Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker.

Meikle PJ, Brooks DA, Ravenscroft EM, Yan M, Williams RE, Jaunzems AE, Chataway TK, Karageorgos LE, Davey RC, Boulter CD, Carlsson SR, Hopwood JJ. Meikle PJ, et al. Among authors: karageorgos le. Clin Chem. 1997 Aug;43(8 Pt 1):1325-35. Clin Chem. 1997. PMID: 9267309

5

CD107a (LAMP-1) and CD107b (LAMP-2).

Chang MH, Karageorgos LE, Meikle PJ. Chang MH, et al. Among authors: karageorgos le. J Biol Regul Homeost Agents. 2002 Apr-Jun;16(2):147-51. J Biol Regul Homeost Agents. 2002. PMID: 12144129 Review. No abstract available.

6

Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.

Karageorgos L, Harmatz P, Simon J, Pollard A, Clements PR, Brooks DA, Hopwood JJ. Karageorgos L, et al. Hum Mutat. 2004 Mar;23(3):229-33. doi: 10.1002/humu.10313. Hum Mutat. 2004. PMID: 14974081 Clinical Trial.

7

Transthyretin interacts with the lysosome-associated membrane protein (LAMP-1) in circulation.

Chang MH, Hua CT, Isaac EL, Litjens T, Hodge G, Karageorgos LE, Meikle PJ. Chang MH, et al. Among authors: karageorgos le. Biochem J. 2004 Sep 1;382(Pt 2):481-9. doi: 10.1042/BJ20031752. Biochem J. 2004. PMID: 15200388 Free PMC article.

8

An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.

Brooks DA, Gibson GJ, Karageorgos L, Hein LK, Robertson EF, Hopwood JJ. Brooks DA, et al. Mol Genet Metab. 2005 Jul;85(3):236-8. doi: 10.1016/j.ymgme.2005.02.008. Epub 2005 Mar 24. Mol Genet Metab. 2005. PMID: 15979036

9

Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy.

Karageorgos L, Brooks DA, Harmatz P, Ketteridge D, Pollard A, Melville EL, Parkinson-Lawrence E, Clements PR, Hopwood JJ. Karageorgos L, et al. Mol Genet Metab. 2007 Feb;90(2):164-70. doi: 10.1016/j.ymgme.2006.10.008. Epub 2006 Dec 11. Mol Genet Metab. 2007. PMID: 17161971 Clinical Trial.

10

Bovine mucopolysaccharidosis type IIIB.

Karageorgos L, Hill B, Bawden MJ, Hopwood JJ. Karageorgos L, et al. J Inherit Metab Dis. 2007 Jun;30(3):358-64. doi: 10.1007/s10545-007-0539-5. Epub 2007 Apr 24. J Inherit Metab Dis. 2007. PMID: 17458708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters